(Total Views: 138)
Posted On: 11/13/2024 11:21:55 AM
Post# of 587
10 Q was released yesterday and reading and thinking outside the box led me
to buy more shares. What if reading between the lines we are moving toward a partner/merger? Good news maybe but always a downside like dilution?
https://app.quotemedia.com/data/downloadFilin...2024-11-12
In anticipation of receiving a Class III PMA (which cannot be assured), we are evaluating paths to rapidly grow our revenue and profits in all potential market segments, with the objective of maximizing shareholder value. We do not intend to pursue the full commercialization of our products independently nor to remain an independent company in the long term. Options under consideration include (i) a sale or merger of the Company with an industry leader in the wound care and surgical device sectors, which may include a pre-sale collaboration on commercialization and distribution and (ii) one or more commercial partnerships with established market participants, without any specific, associated sale or merger transaction.
Lets hope there is a big pharm ready to make a move?
to buy more shares. What if reading between the lines we are moving toward a partner/merger? Good news maybe but always a downside like dilution?
https://app.quotemedia.com/data/downloadFilin...2024-11-12
In anticipation of receiving a Class III PMA (which cannot be assured), we are evaluating paths to rapidly grow our revenue and profits in all potential market segments, with the objective of maximizing shareholder value. We do not intend to pursue the full commercialization of our products independently nor to remain an independent company in the long term. Options under consideration include (i) a sale or merger of the Company with an industry leader in the wound care and surgical device sectors, which may include a pre-sale collaboration on commercialization and distribution and (ii) one or more commercial partnerships with established market participants, without any specific, associated sale or merger transaction.
Lets hope there is a big pharm ready to make a move?
(0)
(0)
